The Home of the Life Sciences Industry

Explore Latest News

Nektar Forms New Subsidiary in Anticipation of Opioid Medication Approval

Inheris Biopharma was formed as Nektar awaits the FDA approval of a pain medication that does not have the euphoric side effects of other opioids.
lucarista / Shutterstock

Novartis' SMA Gene Therapy Treatment Approved by FDA, Priced at $2.125 Million

The price of the one-and-done gene therapy treatment is about half of what was initially projected by Novartis.

Get personalized job alerts

Create a job alert and receive custom job recommendations straight to your inbox.


Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.

Post Jobs Now